{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T23:04:34Z","timestamp":1793833474120,"version":"4.6.1"},"reference-count":35,"publisher":"American Society of Hematology","issue":"5","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2007,3,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Data on 23 patients with low-grade non-Hodgkin lymphomas (NHLs), 4 mantle (MT), 4 marginal zone (MZ), and 15 follicular (FL), were analyzed and compared with 10 high-risk (HR) B-cell chronic lymphocytic leukemias (B-CLLs) with lymph node involvement and 4 diffuse large-cell lymphomas (DLCLs). A significant increase in circulating V\u03b41 T lymphocytes producing interleukin-4 (IL-4) was found in patients with FL, MT, and MZ NHL, at variance with DLCL and HR B-CLL. IL-4 was also detectable in the sera and lymph nodes of the same patients. In 19 of the 23 patients with NHL with increased circulating V\u03b41 T lymphocytes, B cells expressing the UL-16\u2013binding proteins (ULBPs) ULBP2 or ULBP3 or both were found in peripheral blood, bone marrow, or lymph nodes. Of note, in HR B-CLL or in DLCL, where leukemic cells were negative for ULBPs, no V\u03b41 T-cell increase was found. Moreover, V\u03b41 T lymphocytes from patients with FL NHL proliferate in response to ULBP2+ and ULBP3+ lymphoma cells. Finally, patients with high expression of ULBPs, increased circulating V\u03b41 T lymphocytes, and high levels of serum IL-4 showed stable disease in a 1-year follow-up in contrast to patients with low circulating V\u03b41 T cells and undetectable IL-4 or ULBPs.<\/jats:p>","DOI":"10.1182\/blood-2006-06-028985","type":"journal-article","created":{"date-parts":[[2006,9,15]],"date-time":"2006-09-15T01:36:32Z","timestamp":1158284192000},"page":"2078-2085","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":58,"title":["Expansion of V\u03b41 T lymphocytes producing IL-4 in low-grade non-Hodgkin lymphomas expressing UL-16\u2013binding proteins"],"prefix":"10.1182","volume":"109","author":[{"given":"Silvia","family":"Catellani","sequence":"first","affiliation":[{"name":"Laboratory of Hematology, University of Genoa, Genoa, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Poggi","sequence":"additional","affiliation":[{"name":"Experimental Oncology D, National Institute for Cancer Research, Genoa, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Bruzzone","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, University of Genoa, Genoa, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrizia","family":"Dadati","sequence":"additional","affiliation":[{"name":"Department of Pathology, San Martino Hospital, University of Genoa, Genoa, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean Louis","family":"Ravetti","sequence":"additional","affiliation":[{"name":"Department of Pathology, San Martino Hospital, University of Genoa, Genoa, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Gobbi","sequence":"additional","affiliation":[{"name":"Laboratory of Clinical Hematology, University of Genoa, Genoa, Italy; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Raffaella","family":"Zocchi","sequence":"additional","affiliation":[{"name":"Laboratory of Tumor Immunology, San Raffaele Scientific Institute, Milan, Italy."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2006,9,14]]},"reference":[{"key":"2019111712524238600_B1","doi-asserted-by":"crossref","unstructured":"Caligaris-Cappio F and Hamblin TJ. B-cell chronic lymphocytic leukaemia: a bird of a different fea. J Clin Oncol1999; 17:399\u2013408.","DOI":"10.1200\/JCO.1999.17.1.399"},{"key":"2019111712524238600_B2","doi-asserted-by":"crossref","unstructured":"Vose JM, Chiu BCH, Cheson BD, Dancey J, Wright J. Update in epidemiology and therapeutics for non Hodgkin lymphoma. Hematology2002; 78:241\u2013262.","DOI":"10.1182\/asheducation-2002.1.241"},{"key":"2019111712524238600_B3","doi-asserted-by":"crossref","unstructured":"Smyth MJ and Trapani JA. Lymphocyte-mediated immunosurveillance of epithelial cancers? Trends Immunol2001; 22:409\u2013411.","DOI":"10.1016\/S1471-4906(01)01977-9"},{"key":"2019111712524238600_B4","doi-asserted-by":"crossref","unstructured":"Street SE, Hayakawa Y, Zhan Y, et al. Innate immune surveillance of spontaneous B cell lymphoma by natural killer and gammadelta T cells. J Exp Med2004; 199:879\u2013884.","DOI":"10.1084\/jem.20031981"},{"key":"2019111712524238600_B5","doi-asserted-by":"crossref","unstructured":"Girardi M, Oppenheim DE, Steele CR, et al. Regulation of cutaneous malignancies by gamma-delta T cells. Science2001; 294:605\u2013609.","DOI":"10.1126\/science.1063916"},{"key":"2019111712524238600_B6","doi-asserted-by":"crossref","unstructured":"Ferrarini M, Ferrero E, Dagna L, Poggi A, Zocchi MR. Human \u03b3\u03b4 T lymphocytes: a nonredundant system in the immune surveillance against cancer. Trends Immunol2002; 23:14\u201318.","DOI":"10.1016\/S1471-4906(01)02110-X"},{"key":"2019111712524238600_B7","doi-asserted-by":"crossref","unstructured":"Hayday AC. \u03b3\u03b4 T cells: a right time and a right place for a conserved third way of protection. Annu Rev Immunol2000; 18:975\u20131026.","DOI":"10.1146\/annurev.immunol.18.1.975"},{"key":"2019111712524238600_B8","doi-asserted-by":"crossref","unstructured":"Fisch P, Malkovsky M, Kovcats S, et al. Recognition by human V\u03b39\/V\u03b42 T cells of a GroEl homolog on Daudi Burkitt's lymphoma cells. Science1990; 250:1269\u20131273.","DOI":"10.1126\/science.1978758"},{"key":"2019111712524238600_B9","doi-asserted-by":"crossref","unstructured":"Kunzman V, Bauer E, Feurle J, Weissinger F, Tony HP, Wilhelm M. Stimulation of \u03b3\u03b4 T cells by aminobiphosphonates and induction of anti-plasma cell activity in multiple myeloma. Blood2000; 96:384\u2013392.","DOI":"10.1182\/blood.V96.2.384.013k07_384_392"},{"key":"2019111712524238600_B10","doi-asserted-by":"crossref","unstructured":"Maeurer MJ, Martin D, Walter W, et al. Human intestinal Vdelta1+ lymphocytes recognize tumor cells of epithelial origin. J Exp Med1996; 183:1681\u20131696.","DOI":"10.1084\/jem.183.4.1681"},{"key":"2019111712524238600_B11","doi-asserted-by":"crossref","unstructured":"Ferrarini M, Heltai S, Pupa SM, Menard S, Zocchi MR. Killing of laminin-receptor-positive human lung cancers by tumor infiltrating lymphocytes bearing \u03b3\u03b4+ T cell receptors. J Natl Cancer Inst1996; 88:436\u2013441.","DOI":"10.1093\/jnci\/88.7.436"},{"key":"2019111712524238600_B12","doi-asserted-by":"crossref","unstructured":"Lamb LS Jr, Henslee-Downey PJ, Parrish RS, et al. Increased frequency of TCR \u03b3\u03b4+ T cells in disease-free survivors following T cell-depleted, partially mismatched, related donor bone marrow transplantation. J Hematother1996; 5:503\u2013509.","DOI":"10.1089\/scd.1.1996.5.503"},{"key":"2019111712524238600_B13","doi-asserted-by":"crossref","unstructured":"Salih HR, Antropius H, Gieseke F, et al. Functional expression and release of ligands for the activating immunoreceptor NKG2D in leukemia. Blood2003; 102:1389\u20131396.","DOI":"10.1182\/blood-2003-01-0019"},{"key":"2019111712524238600_B14","doi-asserted-by":"crossref","unstructured":"Poggi A, Venturino C, Catellani S, et al. V\u03b41 T lymphocytes from B-CLL patients recognize ULBP3 expressed on leukemic B cells and upregulated by transretinoic acid. Cancer Res2004; 64:9172\u20139179.","DOI":"10.1158\/0008-5472.CAN-04-2417"},{"key":"2019111712524238600_B15","doi-asserted-by":"crossref","unstructured":"Wilhelm M, Kunzmann V, Eckstein S, et al. \u03b3\u03b4 T cells for immune therapy of patients. Blood2003; 102:200\u2013206.","DOI":"10.1182\/blood-2002-12-3665"},{"key":"2019111712524238600_B16","doi-asserted-by":"crossref","unstructured":"Tanaka Y, Morita CT, Nieves E, Brenner MB, Bloom BR. Natural and synthetic non-peptide antigens recognized by human \u03b3\u03b4 T cells. Nature1995; 375:155\u2013158.","DOI":"10.1038\/375155a0"},{"key":"2019111712524238600_B17","doi-asserted-by":"crossref","unstructured":"Kaufman SH. \u03b3\u03b4 and other unconventional T lymphocytes: what do they see and what do they do? Proc Natl Acad Sci U S A1996; 93:2272\u20132279.","DOI":"10.1073\/pnas.93.6.2272"},{"key":"2019111712524238600_B18","doi-asserted-by":"crossref","unstructured":"Morita CT, Beckman EM, Bukowski JF, et al. Direct presentation of nonpeptide prenyl pyrophosphate antigen to human \u03b3\u03b4 T cells. Immunity1995; 3:495\u2013507.","DOI":"10.1016\/1074-7613(95)90178-7"},{"key":"2019111712524238600_B19","doi-asserted-by":"crossref","unstructured":"Groh V, Rhinehart R, Secrist H, Bauer S, Grabstein KH, Spies T. Broad tumor-associated expression and recognition by tumor-derived \u03b3\u03b4 T cells of MIC-A and MIC-B. Proc Natl Acad Sci U S A1999; 96:6879\u20136884.","DOI":"10.1073\/pnas.96.12.6879"},{"key":"2019111712524238600_B20","doi-asserted-by":"crossref","unstructured":"Groh V, Steinle A, Bauer S, Spies T. Recognition of stress-induced MHC molecules by \u03b3\u03b4 T cells. Science1998; 279:1737\u20131740.","DOI":"10.1126\/science.279.5357.1737"},{"key":"2019111712524238600_B21","unstructured":"Pende D, Rivera P, Marcenaro S, et al. Major histocompatibility complex class I-related chain A and UL16-binding protein expression on tumor cell lines of different histotypes: analysis of tumor susceptibility to NKG2D-dependent natural killer cell cytoxicity. Cancer Res2002; 62:6178\u20136186."},{"key":"2019111712524238600_B22","doi-asserted-by":"crossref","unstructured":"Cosman D, Mullberg J, Sutherland CL, et al. ULBPs, novel MHC class-I-related molecules, bind to CMV glycoprotein UL16 and stimulate NK cytotoxicity through the NKG2D receptor. Immunity2001; 14:123\u2013133.","DOI":"10.1016\/S1074-7613(09)00098-3"},{"key":"2019111712524238600_B23","doi-asserted-by":"crossref","unstructured":"Das H, Groh V, Kuijl C, et al. MICA engagement by human V\u03b32\/V\u03b42 T cells enhances their antigen-dependent effector functions. Immunity2001; 15:83\u201393.","DOI":"10.1016\/S1074-7613(01)00168-6"},{"key":"2019111712524238600_B24","doi-asserted-by":"crossref","unstructured":"Steinle A, Li P, Morris DL, et al. Interaction of human NKG2D with its ligands MICA, MICB, and homologs of the mouse RAE-1 protein family. Immunogenetics2001; 53:279\u2013287.","DOI":"10.1007\/s002510100325"},{"key":"2019111712524238600_B25","doi-asserted-by":"crossref","unstructured":"Harris NL, Jaffe ES, Stein H, et al. A Revised European-American classification of lymphoid neoplasms. A proposal from the International Lymphoma Study Group. Blood1994; 84:1361\u20131392.","DOI":"10.1182\/blood.V84.5.1361.bloodjournal8451361"},{"key":"2019111712524238600_B26","doi-asserted-by":"crossref","unstructured":"Cheson BD, Bennet JM, Grever M, et al. National Cancer Institute-sponsored Working Group guidelines for chronic lymphocytic leukaemia: revised guidelines for diagnosis and treatment. Blood1996; 87:4990\u20134997.","DOI":"10.1182\/blood.V87.12.4990.bloodjournal87124990"},{"key":"2019111712524238600_B27","doi-asserted-by":"crossref","unstructured":"Rai KR and Han T. Prognostic factor and clinical staging in chronic lymphocytic leukaemia. Hematol Oncol Clin North Am1990; 4:447\u2013456.","DOI":"10.1016\/S0889-8588(18)30497-0"},{"key":"2019111712524238600_B28","unstructured":"Garcia-Sanz R, Vargas Montero M, Gonzalez Diaz M, et al. Detection of single and associated lesions of the Bcl-1, Bcl-2, Bcl-6, c-myc, p53 and p16 genes in B-cell non-Hodgkin's lymphoma: value of molecular analysis for a better assignment of the histologic subtype. Haematologica1998; 83:209\u2013216."},{"key":"2019111712524238600_B29","doi-asserted-by":"crossref","unstructured":"Jones EA, Pringle JH, Angel CA, Rees RC. Th1\/Th2 cytokine expression and its relationship with tumor grow in B cell non Hodgkin's lymphoma (NHL). Leuk Lymphoma2002; 43:1313\u20131221.","DOI":"10.1080\/10428190290026385"},{"key":"2019111712524238600_B30","doi-asserted-by":"crossref","unstructured":"Damle RN, Dasil T, Fais F, et al. Ig V gene mutational status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukaemia. Blood1999; 94:1840\u20131847.","DOI":"10.1182\/blood.V94.6.1840.418k06_1840_1847"},{"key":"2019111712524238600_B31","doi-asserted-by":"crossref","unstructured":"Diefenbach A, Jamieson AM, Liu SD, Shastri N, Raulet DH. Ligands for the murine NKG2D receptor: expression by tumor cells and activation of NK cells and macrophages. Nat Immunol2000; 1:119\u2013126.","DOI":"10.1038\/77793"},{"key":"2019111712524238600_B32","doi-asserted-by":"crossref","unstructured":"Bonnefoix T, Gressin R, Jacrot M, Swiercz P, Chaffanjon P, Sotto JJ. Growth modulation of freshly isolated non-Hodgkin's B-lymphoma cells by various cytokines and all-trans-retinoic acid. Leuk Lymphoma1997; 25:169\u2013178.","DOI":"10.3109\/10428199709042507"},{"key":"2019111712524238600_B33","doi-asserted-by":"crossref","unstructured":"McHeyzer-Williams MG. Combination of interleukins 2, 4 and 5 regulate the secretion of murine immunoglobulin isotypes. Eur J Immunol1989; 19:2025\u20132030.","DOI":"10.1002\/eji.1830191109"},{"key":"2019111712524238600_B34","doi-asserted-by":"crossref","unstructured":"Lopez RD. Human gammadelta-T cells in adoptive immunotherapy of malignant and infectious disease. Immunol Res2002; 26:207\u201321.","DOI":"10.1385\/IR:26:1-3:207"},{"key":"2019111712524238600_B35","doi-asserted-by":"crossref","unstructured":"Cerwenka A, Bakker AB, McClanahan T, et al. Retinoic acid early inducible genes define a ligand family for the activating NKG2D receptor in mice. Immunity2000; 12:721\u2013727.","DOI":"10.1016\/S1074-7613(00)80222-8"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/109\/5\/2078\/1479062\/zh800507002078.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/109\/5\/2078\/1479062\/zh800507002078.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,17]],"date-time":"2019-11-17T17:53:01Z","timestamp":1574013181000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/109\/5\/2078\/23248\/Expansion-of-V%CE%B41-T-lymphocytes-producing-IL4-in"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,9,14]]},"references-count":35,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2006,9,14]]},"published-print":{"date-parts":[[2007,3,1]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2006-06-028985","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,9,14]]}}}